Gossamer Bio (GOSS) Debt to Equity: 2022-2024
Historic Debt to Equity for Gossamer Bio (GOSS) over the last 2 years, with Mar 2024 value amounting to $0.36.
- Gossamer Bio's Debt to Equity rose 149.01% to $0.36 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.36, marking a year-over-year increase of 149.01%. This contributed to the annual value of $0.20 for FY2023, which is 89.87% down from last year.
- Latest data reveals that Gossamer Bio reported Debt to Equity of $0.36 as of Q1 2024, which was up 81.25% from $0.20 recorded in Q4 2023.
- Gossamer Bio's 5-year Debt to Equity high stood at $1.95 for Q4 2022, and its period low was -$1.07 during Q2 2022.
- Its 3-year average for Debt to Equity is $0.20, with a median of $0.20 in 2023.
- As far as peak fluctuations go, Gossamer Bio's Debt to Equity plummeted by 175.70% in 2023, and later spiked by 149.01% in 2024.
- Gossamer Bio's Debt to Equity (Quarterly) stood at $1.95 in 2022, then crashed by 89.87% to $0.20 in 2023, then soared by 149.01% to $0.36 in 2024.
- Its Debt to Equity was $0.36 in Q1 2024, compared to $0.20 in Q4 2023 and $0.15 in Q3 2023.